Aesthetics Biomedical Teams Up With U.S. Dermatology Partners

Aesthetics Biomedical announced a long-term partnership with U.S. Dermatology Partners, the largest physician-led dermatology practice in the U.S. The partnership includes offering Vivace, a minimally invasive, FDA-cleared, radiofrequency microneedling treatment that stimulates the natural production of collagen and has been shown by physicians to be effective in alleviating facial wrinkles, fine lines, and tightening the face and neck. Aesthetics Biomedical will help U.S. Dermatology Partners’ in practice success with technology, devices, and products supported by science, customer-focused market recognition, rigorous and continuing education, and strong continuous return on investment. 

U.S. Dermatology Partners CEO Paul Singh says, "U.S. Dermatology Partners is thrilled to be collaborating with Aesthetics Biomedical to bring the Vivace Experience to our patients and our growing network to Aesthetics Biomedical," says Paul Singh, CEO of U.S. Dermatology Partners. "We expect the innovative technology and outstanding results that Vivace offers will be well-received by both our physicians and patients and will provide another opportunity to deliver superior care to the communities we serve."

Related Articles 

Aesthetics Biomedical Announces New Ambassadorship Program  

Aesthetics Biomedical Announces Partnership Plasma Concepts 

Aesthetics Biomedical Appoints Four World-Renowned Experts to Clinical Advisory Board